Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma
Clinical trial NCT07761286 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07761286
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2029-09-30
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.